Cargando…
The Taming of Nuclear Factor Erythroid-2-Related Factor-2 (Nrf2) Deglycation by Fructosamine-3-Kinase (FN3K)-Inhibitors-A Novel Strategy to Combat Cancers
SIMPLE SUMMARY: Aim of this review is to provide an overview on (a) Fructosamine-3-Kinase (FN3K) and its role in regulating Nuclear Factor Erythorid-2-Related Factor-2 (Nrf2); (b) the role of glycation and deglycation mechanisms in modulating the functional properties of proteins, in particular, the...
Autores principales: | Beeraka, Narasimha M., Bovilla, Venugopal R., Doreswamy, Shalini H., Puttalingaiah, Sujatha, Srinivasan, Asha, Madhunapantula, SubbaRao V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7828646/ https://www.ncbi.nlm.nih.gov/pubmed/33466626 http://dx.doi.org/10.3390/cancers13020281 |
Ejemplares similares
-
Screening fructosamine-3-kinase (FN3K) inhibitors, a deglycating enzyme of oncogenic Nrf2: Human FN3K homology modelling, docking and molecular dynamics simulations
por: Beeraka, Narasimha M., et al.
Publicado: (2023) -
The Role of Exosomes in Stemness and Neurodegenerative Diseases—Chemoresistant-Cancer Therapeutics and Phytochemicals
por: Beeraka, Narasimha M., et al.
Publicado: (2020) -
Enzymatic Deglycation of Damaged Skin by Means of Combined Treatment of Fructosamine-3-Kinase and Fructosyl-Amino Acid Oxidase
por: De Decker, Ignace, et al.
Publicado: (2023) -
The Current Status and Challenges in the Development of Vaccines and Drugs against Severe Acute Respiratory Syndrome-Corona Virus-2 (SARS-CoV-2)
por: Beeraka, Narasimha M., et al.
Publicado: (2021) -
A Review on SARS-CoV-2-Induced Neuroinflammation, Neurodevelopmental Complications, and Recent Updates on the Vaccine Development
por: Karnik, Medha, et al.
Publicado: (2021)